56 results
Page 2 of 3
8-K
EX-99.1
t8327i5g 0e6diuvu6
30 Mar 20
PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
8:08am
S-3
EX-4.2
610 d85855
27 Dec 19
Shelf registration
5:28pm
S-3
nxycuzv
27 Dec 19
Shelf registration
5:28pm
8-K
EX-99.1
aotx molpcuf49x
14 Nov 19
PhaseBio Reports Third Quarter 2019 Financial Results and Recent Corporate Progress
8:16am
8-K
EX-99.1
531xb8ooowct9wfu
13 Aug 19
PhaseBio Reports Second Quarter 2019 Financial Results and Recent Corporate Progress
4:05pm
8-K
EX-99.1
kqal d9z56n
9 May 19
PhaseBio Reports First Quarter 2019 Financial and Business Results
4:05pm
424B4
qcxtrpr
12 Apr 19
Prospectus supplement with pricing info
4:32pm
8-K
EX-10.1
0he 4vdsxwt3uim
9 Apr 19
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
8:01am
DRS
4tjs9xwzpnh2z6ty9ib2
29 Mar 19
Draft registration statement
12:00am
10-K
f9lt15 plitpyg3soi4
26 Mar 19
Annual report
4:45pm
10-K
EX-10.14
cq2xsbnjt
26 Mar 19
Annual report
4:45pm
10-K
EX-10.13
bhl8m
26 Mar 19
Annual report
4:45pm